Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-12-20Clinical Trial Update: Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
A Phase 2 safety and efficacy study of gemcitabine plus bevacizumab for platinum-resistant ovarian, fallopian tube, or primary peritoneal ca…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial evaluating pazopanib monotherapy as a second-line treatment after first-line chemotherapy in ovarian, fallopian tube, or prima…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
A Phase 2 study evaluating CP-547,632 in recurrent or persistent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has co…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating platinum-based chemotherapy with or without paclitaxel for relapsed ovarian cancer and primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer [Phase 3]
A Phase 3 clinical trial comparing carboplatin plus paclitaxel versus carboplatin plus docetaxel in ovarian cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of squalamine lactate and carboplatin for recurrent or refractory stage III/IV ovaria…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer [Phase 3]
A Phase 3 trial comparing adjuvant chemotherapy versus observation in patients with resected early-stage ovarian epithelial cancer; the curr…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Screening Women at High Genetic Risk for Ovarian Cancer [NA]
The clinical trial evaluating screening for ovarian cancer in women at high genetic risk has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Phase 2]
Phase 2 trial evaluating enoxaparin thromboprophylaxis in cancer patients with elevated tissue factor-bearing microparticles has completed w…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing early chemotherapy based on CA 125 levels versus delayed chemotherapy in recurrent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer [Phase 3]
Phase 3 trial comparing chemotherapy with versus without surgery for Stage II/III ovarian cancer has completed. The update notes completion …
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors [Phase 2]
Phase 2 clinical trial update on combination chemotherapy for pediatric metastatic rhabdomyosarcoma and other malignant mesenchymal tumors; …
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer [Phase 3]
Phase 3 randomized trial comparing Telcyta plus doxorubicin versus doxorubicin alone in platinum-refractory or resistant ovarian cancer has …
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating Hu3S193 in women with ovarian epithelial, primary peritoneal, or fallopian tube cancer has completed, and results h…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating irinotecan in patients with refractory ovarian epithelial, primary peritoneal, or fallopian tube cancer …
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer [Phase 1]
A Phase 1 study evaluating safety, tolerability and pharmacokinetics of MORAb-003 (farletuzumab) in patients with advanced ovarian cancer re…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update of a monoclonal antibody therapy for ovarian, fallopian tube, and primary peritoneal cancer sponsored by AltaR…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating a monoclonal antibody therapy in patients with residual disease after surgery and chemotherapy for stage I…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study [NA]
A feasibility trial evaluating yoga to improve quality of life in patients with ovarian, fallopian tube, or primary peritoneal cancer receiv…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]
This entry reports an ongoing Phase 2 clinical trial evaluating the combination of IM-862 with chemotherapy for patients with resected stage…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update investigating a gene therapy for women with refractory or relapsed ovarian epithelial cancer, fallopian tube c…
-
CLINICAL_TRIALS research · 2013-11-01Clinical Trial Update: Hypodontia and Ovarian Cancer
Clinical trial update from the University of Aarhus involves ovarian cancer and hypodontia, with related conditions including breast cancer …
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide [Phase 1]
Phase 1 trial evaluating EMD 273066 in EpCAM-positive recurrent ovarian, prostate, colorectal, or non-small cell lung cancer when first trea…